The association of serum insulin-like growth factor-I with mortality, cardiovascular disease, and cancer in the elderly: A population-based study

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 10, 2010, Pages 4616-4624

  Van Bunderen, Christa C ^a   Van Nieuwpoort, I Caroline ^a   Van Schoor, Natasja M ^a   Deeg, Dorly J H ^a   Lips, Paul ^a   Drent, Madeleine L ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ADULT; AGED; AGING; ARTICLE; BLOOD SAMPLING; CANCER MORTALITY; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COLORECTAL CANCER; COMMUNITY SAMPLE; CONCENTRATION (PARAMETERS); DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; ELDERLY CARE; FEMALE; FOLLOW UP; HAZARD RATIO; HEART MUSCLE ISCHEMIA; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LONGITUDINAL STUDY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; SELF REPORT;

EID: 77957801613     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0940     Document Type: Article

References (34)

1. Lamberts SW, van den Beld AW, van der Lely AJ 1997 The endocrinology of aging. Science 278:419-424
2. Rosen CJ 2000 Growth hormone and aging. Endocrine 12:197-201
3. Juul A 2003 Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 13:113-170 (Pubitemid 36986557)
4. Andreassen M, Raymond I, Kistorp C, Hildebrandt P, Faber J, Kristensen LØ 2009 IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. Eur J Endocrinol 160:25-31
5. Cappola AR, Xue QL, Ferrucci L, Guralnik JM, Volpato S, Fried LP 2003 Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab 88:2019-2025 (Pubitemid 36549871)
6. Friedrich N, Haring R, Nauck M, Lüdemann J, Rosskopf D, Spilcke-Liss E, Felix SB, Dörr M, Brabant G, Völzke H, Wallaschofski H 2009 Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations. J Clin Endocrinol Metab 94:1732-1739
7. Fürstenberger G, Senn HJ 2002 Insulin-like growth factors and cancer. Lancet Oncol 3:298-302
8. Janssen JA, Stolk RP, Pols HA, Grobbee DE, Lamberts SW 1998 Serum total IGF-I, free IGF-I, and IGFBP-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol 18:277-282 (Pubitemid 28277606)
9. Johnsen SP, Hundborg HH, Sørensen HT, Orskov H, Tjønneland A, Overvad K, Jørgensen JO 2005 Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab 90:5937-5941 (Pubitemid 41606508)
10. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE 2000 The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215-244 (Pubitemid 32275588)
11. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M 2004 Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346-1353
12. Schneider HJ, Klotsche J, Saller B, Böhler S, Sievers C, Pittrow D, Ruf G, März W, Erwa W, Zeiher AM, Silber S, Lehnert H, Wittchen HU, Stalla GK 2008 Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: cross-sectional study in 6773 primary care patients. Eur J Endocrinol 158:153-161
13. Scacchi M, Cavagnini F 2006 Acromegaly. Pituitary 9:297-303
14. Rosén T, Bengtsson BA 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285-288 (Pubitemid 20229130)
15. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jørgensen T 2002 Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 106:939-944 (Pubitemid 34925327)
16. Berryman DE, Christiansen JS, Johannsson G, Thorner MO, Kopchick JJ 2008 Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models. Growth Horm IGF Res 18:455-471
17. Katic M, Kahn CR 2005 The role of insulin and IGF-1 signaling in longevity. Cell Mol Life Sci 62:320-343 (Pubitemid 40379247)
18. Ruiz-Torres A, Soares de Melo Kirzner M 2002 Ageing and longevity are related to growth hormone/insulin-like growth factor-1 secretion. Gerontology 48:401-407 (Pubitemid 36152992)
19. Janssen JA, Lamberts SW 2004 Igf-I and longevity. Horm Res 62(Suppl 3):104-109
20. Deeg DJ, Knipscheer CP, van Tilburg W 1993 Autonomy and well-being in the aging population: concepts and design of the Longitudinal Aging Study Amsterdam. Bunnik, The Netherlands: Netherlands Institute of Gerontology
21. Garretsen HFL 1983 Probleemdrinken: prevalentiebepaling, beinvloedende factoren en preventiemogelijkheden. Theoretische overwegingen en onderzoek in Rotterdam. Ph.D. thesis/dissertation, Radboud University Nijmegen. Lisse, The Netherlands
22. Clase CM, St Pierre MW, Churchill DN 2001 Conversion between bromcresol green- and bromcresol purple-measured albumin in renal disease. Nephrol Dial Transplant 16:1925-1929
23. Giovannucci E 1999 Insulin-like growth factor-I and binding protein-3 and risk of cancer. Horm Res 51(Suppl 3):34-41
24. Rinaldi S, Cleveland R, Norat T, Biessy C, Rohrmann S, Linseisen J, Boeing H, Pischon T, Panico S, Agnoli C, Palli D, Tumino R, Vineis P, Peeters PH, van Gils CH, Bueno-de-Mesquita BH, Vrieling A, Allen NE, Roddam A, Bingham S, Khaw KT, Manjer J, Borgquist S, Dumeaux V, Torhild Gram I, Lund E, Trichopoulou A, Makrygiannis G, Benetou V, Molina E, Donate Suárez I, Barricarte Gurrea A, Gonzalez CA, Tormo MJ, Altzibar JM, Olsen A, Tjonneland A, Grønbaek H, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Morois S, Slimani N, Boffetta P, Jenab M, Riboli E, Kaaks R 2010 Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer 126:1702-1715
25. Major JM, Laughlin GA, Kritz-Silverstein D, Wingard DL, Barrett-Connor E 2010 Insulin-like growth factor-I and cancer mortality in older men. J Clin Endocrinol Metab 95:1054-1059
26. Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D 2004 The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab 89:114-120 (Pubitemid 38183869)
27. Saydah S, Graubard B, Ballard-Barbash R, Berrigan D 2007 Insulin-like growth factors and subsequent risk of mortality in the United States. Am J Epidemiol 166:518-526 (Pubitemid 47283642)
28. Colao A 2008 The GH-IGF-I axis and the cardiovascular system: clinical implications. Clin Endocrinol (Oxf) 69:347-358
29. Boquist S, Ruotolo G, Skoglund-Andersson C, Tang R, Björkegren J, Bond MG, de Faire U, Brismar K, Hamsten A 2008 Correlation of serum IGF-I and IGFBP-1 and -3 to cardiovascular risk indicators and early carotid atherosclerosis in healthy middle-aged men. Clin Endocrinol (Oxf) 68:51-58
30. Yeap BB, Chubb SA, Ho KK, Setoh JW, McCaul KA, Norman PE, Jamrozik K, Flicker L 2010 Insulin-like growth factor-I and its binding proteins 3 and 1 are differentially associated with metabolic syndrome in older men. Eur J Endocrinol 162:249-257
31. Kriegsman DM, Penninx BW, van Eijk JT, Boeke AJ, Deeg DJ 1996 Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. J Clin Epidemiol 49:1407-1417
32. Samani AA, Yakar S, LeRoith D, Brodt P 2007 The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28:20-47 (Pubitemid 46220849)
33. Brugts MP, van den Beld AW, Hofland LJ, van der Wansem K, van Koetsveld PM, Frystyk J, Lamberts SW, Janssen JA 2008 Low circulating insulin-like growth factor I bioactivity in elderly men is associated with increased mortality. J Clin Endocrinol Metab 93:2515-2522 (Pubitemid 352008515)
34. Rosen CJ, Pollak M 1999 Circulating IGF-I: new perspectives for a new century. Trends Endocrinol Metab 10:136-141 (Pubitemid 29284347)